Evaluation of exposure of health care personnel to ribavirin
- 31 August 1989
- journal article
- research article
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health
- Vol. 28 (1) , 1-12
- https://doi.org/10.1080/15287398909531324
Abstract
Reports that ribavirin was teratogenic in animals raised concerns of female health care personnel about possible occupational exposure during the care of infants having respiratory syncytial virus infections. Under simulated operational conditions, experiments were conducted to measure ribavirin residues in room air, in surface wipe samples, and in personal sampling devices worn by volunteers. There was exposure to a dispersible dust, presumably dried ribavirin, deposited inside the croupette or hood and on the bedding. Based on personal sampler data, it was estimated that, in a 12‐h shift, the primary health care individual could inhale 2.4–9.1 μg ribavirin/kg bw‐d. Recommendations to reduce the exposure of staff included the wearing of appropriate surgical gloves and a NIOSH‐approved disposable respirator for dusts and mists while attending to the needs of the patients.This publication has 7 references indexed in Scilit:
- Environmental exposure of primary care personnel to ribavirin aerosol when supervising treatment of infants with respiratory syncytial virus infectionsAntimicrobial Agents and Chemotherapy, 1987
- Aerosolized ribavirin in the treatment of patients with respiratory syncytial virus diseaseThe Pediatric Infectious Disease Journal, 1987
- Ribavirin: A clinical overviewEuropean Journal of Epidemiology, 1986
- Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary diseaseJAMA, 1985
- Ribavirin aerosol treatment of influenza B virus infectionJAMA, 1983
- Embryotoxic, teratogenic, and metabolic effects of ribavirin in miceToxicology and Applied Pharmacology, 1980
- Teratogenic effects of ribavirin on hamster and rat embryosTeratology, 1978